Bioregenx, Inc. financial data

Symbol
BRGX on OTC
Location
7407 Ziegler Road, Chattanooga, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.23 % -44.8%
Quick Ratio 3.66 %
Debt-to-equity 557 % +1211%
Return On Equity -2.59K % -2152%
Return On Assets -395 % -425%
Operating Margin -939 % -281%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 961M shares +0.48%
Common Stock, Shares, Outstanding 961M shares +0.48%
Entity Public Float 5.59M USD +31.6%
Common Stock, Value, Issued 961K USD +0.48%
Weighted Average Number of Shares Outstanding, Basic 959M shares +0.28%
Weighted Average Number of Shares Outstanding, Diluted 959M shares +0.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.02M USD -26.8%
Cost of Revenue 455K USD -52.3%
Research and Development Expense -33K USD -126%
Operating Income (Loss) -18.9M USD -179%
Nonoperating Income (Expense) -522K USD -258%
Net Income (Loss) Attributable to Parent -19.2M USD -174%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.6K USD -26.7%
Accounts Receivable, after Allowance for Credit Loss, Current 21.1K USD +93%
Inventory, Net 134K USD -6.74%
Other Assets, Current 42.6K USD -60.8%
Assets, Current 250K USD -23.5%
Property, Plant and Equipment, Net 176K USD -22%
Goodwill 7.11M USD
Other Assets, Noncurrent 0 USD -100%
Assets 1.15M USD -93.6%
Accounts Payable, Current 569K USD +31.7%
Employee-related Liabilities, Current 48K USD
Accrued Liabilities, Current 405K USD +1.87%
Liabilities, Current 3.93M USD +14.8%
Liabilities 4.81M USD +30.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.22K USD -1269%
Retained Earnings (Accumulated Deficit) -36M USD -115%
Stockholders' Equity Attributable to Parent -3.65M USD -126%
Liabilities and Equity 1.15M USD -93.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37.7K USD
Net Cash Provided by (Used in) Financing Activities -10.4K USD -104%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 961M shares +0.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 25.2K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.5K USD -19.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.2K USD +693%
Deferred Tax Assets, Valuation Allowance 3.32M USD +128%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.2M USD -174%
Deferred Tax Assets, Operating Loss Carryforwards 1.37M USD +94.3%
Additional Paid in Capital 31.4M USD +4.55%
Amortization of Intangible Assets 562K USD
Depreciation, Depletion and Amortization 521K USD +937%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 71.1K USD +7.17%